{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:35:53Z","timestamp":1787841353746,"version":"build-2784847793"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,29]],"date-time":"2014-09-29T00:00:00Z","timestamp":1411948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,10]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Cancer and its treatment are recognized risk factors for venous thromboembolism (VTE). Inferior vena cava (IVC) filters are utilized to provide mechanical thromboprophylaxis to prevent pulmonary embolism (PE) or to avoid bleeding from systemic anticoagulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PATIENTS AND METHODS:<\/jats:title>\n                    <jats:p>A retrospective analysis of 107 cancer patients who had IVC filters inserted and followed up at our institution was performed. All patients had active cancer; a majority (&gt; 90%) had advanced-stage disease, whereas only five patients (5.8%) had stages I or II disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Eighty six patients (80.3%) had their IVC filter placed through a jugular approach. Filter insertion was not without complications; recurrent deep vein thrombosis (DVT) was reported in 10 (9.3%), PE in three (2.8%) and filter thrombosis in one patient. The value of IVC filter in patients with advanced stage disease was very limited: among 59 patients with stage IV disease for whom survival data was available, the median survival was only 1.31 months (0.92-2.20) with 23 patients (39.0%) surviving less than a month, and 40 (67.8%) surviving less than three months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Systemic anticoagulation can be safely offered for the majority of cancer patients. When the risk of bleeding or PE is high, IVC filters can be utilized. However, the placement of such filters should take into consideration the stage of disease and life expectancy of such patients. Patients with advanced-stage disease may gain little benefit from IVC filter insertion.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.hemonc.2014.09.005","type":"journal-article","created":{"date-parts":[[2014,10,7]],"date-time":"2014-10-07T12:24:14Z","timestamp":1412684654000},"page":"136-141","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":18,"title":["Inferior vena cava filters in patients with advanced-stage cancer"],"prefix":"10.4103","volume":"7","author":[{"given":"Asem","family":"Mansour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Ismael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikmat","family":"Abdel-Razeq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"6","key":"10.1016\/j.hemonc.2014.09.005_b0005","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archinte.160.6.809","article-title":"Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study","volume":"160","author":"Heit","year":"2000","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.hemonc.2014.09.005_b0010","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/archinte.162.11.1245","article-title":"Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study","volume":"162","author":"Heit","year":"2002","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.hemonc.2014.09.005_b0015","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1055\/s-0037-1613136","article-title":"Variation in relative risk of venous thromboembolism in different cancers","volume":"87","author":"Thodiyil","year":"2002","journal-title":"Thromb Haemost"},{"issue":"11","key":"10.1016\/j.hemonc.2014.09.005_b0020","doi-asserted-by":"crossref","first-page":"867","DOI":"10.7326\/0003-4819-140-11-200406010-00007","article-title":"Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial","volume":"140","author":"B\u00fcller","year":"2004","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.hemonc.2014.09.005_b0025","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/S0735-1097(02)02381-1","article-title":"Thrombolytic therapy of pulmonary embolism: a meta-analysis","volume":"40","author":"Thabut","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.hemonc.2014.09.005_b0030","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1200\/JCO.1996.14.2.652","article-title":"Inferior vena cava filters in cancer patients: indications and outcome","volume":"14","author":"Schwarz","year":"1996","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.hemonc.2014.09.005_b0035","doi-asserted-by":"crossref","first-page":"446","DOI":"10.4103\/0256-4947.57166","article-title":"Inferior vena caval filters: 5years of experience in a tertiary care center","volume":"29","author":"Saour","year":"2009","journal-title":"Ann Saudi Med"},{"issue":"16","key":"10.1016\/j.hemonc.2014.09.005_b0040","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1001\/archinternmed.2010.272","article-title":"A population-based study of inferior vena cava filters in patients with acute venous thromboembolism","volume":"170","author":"Spencer","year":"2010","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.hemonc.2014.09.005_b0045","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM199802123380701","article-title":"A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis: Pr\u00e9vention du Risque d\u2019Embolie Pulmonaire par Interruption Cave Study Group","volume":"338","author":"Decousus","year":"1998","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.hemonc.2014.09.005_b0050","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/CIRCULATIONAHA.104.512834","article-title":"Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Pr\u00e9vention du Risque d\u2019Embolie Pulmonaire par Interruption Cave) randomized study","volume":"112","author":"PREPIC Study Group","year":"2005","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.hemonc.2014.09.005_b0055","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.thromres.2007.06.017","article-title":"Retrievable vena cava filters: key considerations","volume":"122","author":"Imberti","year":"2008","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.hemonc.2014.09.005_b0060","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.thromres.2010.08.024","article-title":"Retrievable inferior vena cava filters are not getting retrieved: where is the gap?","volume":"126","author":"Dabbagh","year":"2010","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.hemonc.2014.09.005_b0065","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1378\/chest.06-0631","article-title":"A prospective long-term study of 220 patients with a retrievable vena cava filter for secondary prevention of venous thromboembolism","volume":"131","author":"Mismetti","year":"2007","journal-title":"Chest"},{"issue":"2 Suppl.","key":"10.1016\/j.hemonc.2014.09.005_b0070","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed.: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.hemonc.2014.09.005_b0075","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/ana.410130320","article-title":"Incidence and treatment of peripheral venous thrombosis in patients with glioma","volume":"13","author":"Ruff","year":"1983","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.hemonc.2014.09.005_b0080","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1212\/WNL.27.7.650","article-title":"Intracranial hemorrhage caused by metastatic tumors","volume":"27","author":"Mandybur","year":"1977","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.hemonc.2014.09.005_b0085","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1212\/WNL.43.6.1111","article-title":"Complications of therapy for venous thromboembolic disease in patients with brain tumors","volume":"43","author":"Levin","year":"1993","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.hemonc.2014.09.005_b0090","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0741-5214(02)00121-0","article-title":"Inferior vena cava filters in malignant disease","volume":"36","author":"Jarrett","year":"2002","journal-title":"J Vasc Surg"},{"issue":"3","key":"10.1016\/j.hemonc.2014.09.005_b0095","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/1076029608315165","article-title":"Need for inferior vena cava filters in cancer patients: a surrogate marker for poor outcome","volume":"15","author":"Barginear","year":"2009","journal-title":"Clin Appl Thromb Hemost"},{"issue":"4","key":"10.1016\/j.hemonc.2014.09.005_b0100","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/1538574406291821","article-title":"Inferior vena cava filter placement in late-stage cancer","volume":"40","author":"Schunn","year":"2006","journal-title":"Vasc Endovascular Surg"},{"issue":"8","key":"10.1016\/j.hemonc.2014.09.005_b0105","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1002\/cncr.20578","article-title":"Use of inferior vena caval filters and survival in patients with malignancy","volume":"101","author":"Wallace","year":"2004","journal-title":"Cancer"}],"container-title":["Hematology\/Oncology and Stem Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S165838761400082X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S165838761400082X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ovid.com\/02275670-201407040-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:50:19Z","timestamp":1787838619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/02275670-201407040-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1016\/j.hemonc.2014.09.005","relation":{},"ISSN":["1658-3876"],"issn-type":[{"value":"1658-3876","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}